Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
599.50    -5.50 (-0.91%)
Bid:
600.00
Ask:
600.50
Spread: 0.50 (0.083%)
Market Cap: £2.77b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

Commencement of Share Buyback Programme

20 May 2026 07:01

RNS Number : 9849E
RS Group PLC
20 May 2026
 

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

RS GROUP PLC

("RS Group" or the "Company")

 

Commencement of Share Buyback Programme

 

As separately announced today in its full-year results for the financial year ended 31 March 2026, RS Group is today commencing a share buyback programme to purchase ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") for up to a maximum consideration of £100,000,000 (excluding stamp duty and expenses) (the "Buyback").

 

In line with our capital allocation policy and disciplined approach to deploying capital across both organic and M&A opportunities, the Board has reviewed the strength and efficiency of the balance sheet and intends to continue to pursue a progressive dividend policy alongside the Buyback. The Buyback will be conducted over a 12-month period, and the Board will continue to review efficient deployment of capital in line with the capital allocation policy.

 

The Company has entered into an agreement with Barclays Bank PLC ("Barclays") to manage the Buyback. Barclays will carry out the acquisition of Ordinary Shares (on a riskless principal basis) for subsequent repurchase by the Company.

 

Barclays will make trading decisions in relation to the Buyback independently of the Company with regard to the timing of purchases. Any purchase of Ordinary Shares under the Buyback will be carried out during open and closed periods on the London Stock Exchange.

 

The purpose of the Buyback is to reduce the share capital of the Company. The Directors consider the Buyback to be in the best interests of the Company and of its shareholders generally.

 

The Buyback will commence immediately and will end no later than 19 May 2027.

 

Ordinary Shares purchased under the Buyback will be cancelled.

 

Any purchases under the Buyback shall also take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the annual general meeting on 17 July 2025 (the "Existing Authority") and any subsequent authority ("Subsequent Authority"); chapter 9 of the Financial Conduct Authority's Listing Rules; the Market Abuse Regulation (EU) No 596/2014 (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019); and the Commission Delegated Regulation (EU) No 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019). The Buyback will be discontinued in the event the Company ceases to have the necessary general authority to repurchase Ordinary Shares.

 

The maximum number of Ordinary Shares that the Company is authorised to purchase under the Existing Authority is 47,404,946 Ordinary Shares.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUKVBRNAUVAAR
Date   Source Headline
22nd Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 202610:00 amRNSHolding(s) in Company
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202612:00 pmRNSAnnual Financial Report and Notice of AGM
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 202610:00 amRNSDirector/PDMR Shareholding
2nd Jun 20263:55 pmRNSDirector Declaration
1st Jun 202612:43 pmRNSHolding(s) in Company
1st Jun 20269:44 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:01 amRNSCommencement of Share Buyback Programme
20th May 20267:00 amRNSFinal Results
1st Apr 20265:06 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSPre-Close Trading Update
3rd Mar 20267:00 amRNSAcquisition of BPX Group
6th Jan 20264:00 pmRNSDirector/PDMR Shareholding
12th Dec 20253:14 pmRNSDirectorate change
4th Dec 202510:00 amRNSDirector/PDMR Shareholding
20th Nov 20254:20 pmRNSReplacement Holding(s) in Company
20th Nov 20253:30 pmRNSHolding(s) in Company
7th Nov 20253:56 pmRNSHolding(s) in Company
6th Nov 20257:00 amRNSHalf-year Financial Report
1st Sep 20254:30 pmRNSHolding(s) in Company
12th Aug 20254:30 pmRNSHolding(s) in Company
8th Aug 20254:00 pmRNSHolding(s) in Company
1st Aug 202511:02 amRNSBlock listing Interim Review
21st Jul 20254:00 pmRNSDirector/PDMR Shareholding
17th Jul 20253:15 pmRNSResult of AGM
17th Jul 20257:00 amRNSAGM Update
4th Jul 202510:00 amRNSDirectorate Change - Chair of Audit Committee
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jun 20259:00 amRNSDirector/PDMR Shareholding
18th Jun 20254:30 pmRNSDirector/PDMR Shareholding
10th Jun 202511:00 amRNSHolding(s) in Company
9th Jun 202512:00 pmRNSAnnual Financial Report and Notice of AGM
6th Jun 20252:00 pmRNSDirector/PDMR Shareholding
29th May 202510:00 amRNSDirector/PDMR Shareholding
21st May 20257:00 amRNSFinal Results
23rd Apr 20254:30 pmRNSDirector/PDMR Shareholding
28th Mar 20252:30 pmRNSDirector/PDMR Shareholding
26th Mar 202511:00 amRNSDirector/PDMR Shareholding
21st Feb 202510:00 amRNSDirectorate Change
3rd Feb 202510:39 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNS3rd Quarter Trading Update
8th Jan 20259:13 amRNSDirector Declaration
7th Jan 20252:38 pmRNSDirector Declaration
29th Nov 20248:30 amRNSDirectorate Change
7th Nov 20247:00 amRNSHalf-year Report
1st Oct 20249:46 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.